Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Cajal Neuroscience is a drug discovery company built for one purpose: to deliver new medicines that give life back to patients suffering from neurodegenerative disease.
-
Industry
-
Milestones
- Lux investment: 2020
-
Founders
- Ian Peikon, PhD
- Charles Zuker, PhD
- Huda Zoghbi, MD
- Tony Zador, MD, PhD
- Rob Hershberg, MD, PhD
- Andrew Dervan, MD
LUX Partners
-
Latest Tweets
- Come join a fun startup in Seattle working in neuroscience. Looking for a sharp scientist on the rise. https://t.co/R1PmkZWBWr